diagnosis

When Guillain-Barre syndrome is not monophasic: Distinguishing recurrent Guillain-Barre syndrome from acuteonset chronic inflammatory demyelinating polyneuropathy and nodopathies

Clinical Presentation Guillain-Barre syndrome (GBS) typically manifests as a rapid onset of motor weakness, often starting in the legs and […]

When Guillain-Barre syndrome is not monophasic: Distinguishing recurrent Guillain-Barre syndrome from acuteonset chronic inflammatory demyelinating polyneuropathy and nodopathies Read Post »

Response to: Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account

Study Overview The investigation into biomarkers for mild traumatic brain injury (mTBI) has garnered significant attention as the understanding of

Response to: Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account Read Post »

Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account

Background on Biomarkers Biomarkers serve as vital indicators of biological processes, pathogenic processes, or pharmacologic responses to therapeutic interventions. In

Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account Read Post »

Scroll to Top